NeuroPace (NPCE) Non-Current Assets (2020 - 2026)
NeuroPace's (NPCE) quarterly Non-Current Assets came in at $11.9 million in Q1 2026, down 6.34% year-on-year from $12.7 million in Q1 2025, and up 3.72% quarter-over-quarter from $11.5 million in Q4 2025.
NeuroPace (NPCE) Non-Current Assets (2020 - 2026) Analysis & Trends
NeuroPace's Non-Current Assets history runs 7 years deep, the most recent figure standing at $11.9 million for Q1 2026.
- On a quarterly basis, Non-Current Assets fell 6.34% year-over-year to $11.9 million in Q1 2026; TTM through Mar 2026 was $47.7 million, a 11.5% decrease from a year earlier, with the FY2025 full-year figure at $11.5 million, down 13.65% from the prior year.
- Non-Current Assets rose to $11.9 million in Q1 2026 per NPCE's latest filing, from $11.5 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $16.4 million in Q4 2022 and bottomed at $6.1 million in Q2 2022.
- The 5-year median for Non-Current Assets is $13.7 million (2024), against an average of $13.1 million.
- Across the five-year window, Non-Current Assets surged 2097.32% in 2022 and slipped 13.65% in 2025, its largest moves.
- Year by year, Non-Current Assets stood at $16.4 million in 2022, then fell by 8.91% to $14.9 million in 2023, then fell by 10.88% to $13.3 million in 2024, then retreated by 13.65% to $11.5 million in 2025, then gained by 3.72% to $11.9 million in 2026.
- Per Business Quant, the three latest NPCE Non-Current Assets figures stand at $11.9 million (Q1 2026), $11.5 million (Q4 2025), and $11.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn | 11.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.92 Mn |
| Dec 31, 2025 | 11.49 Mn |
| Sep 30, 2025 | 11.93 Mn |
| Jun 30, 2025 | 12.37 Mn |
| Mar 31, 2025 | 12.73 Mn |
| Dec 31, 2024 | 13.31 Mn |
| Sep 30, 2024 | 13.71 Mn |
| Jun 30, 2024 | 14.16 Mn |
| Mar 31, 2024 | 14.60 Mn |
| Dec 31, 2023 | 14.93 Mn |
| Sep 30, 2023 | 15.33 Mn |
| Jun 30, 2023 | 15.72 Mn |
| Mar 31, 2023 | 16.12 Mn |
| Dec 31, 2022 | 16.39 Mn |
| Sep 30, 2022 | 16.10 Mn |
| Jun 30, 2022 | 6.08 Mn |
| Mar 31, 2022 | 6.56 Mn |
| Dec 31, 2021 | 746,000.00 |
| Sep 30, 2021 | 767,000.00 |
| Jun 30, 2021 | 570,000.00 |